Enanta Pharmaceuticals (ENTA) EBT Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.81% |
| Dec 31, 2025 | -0.50% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | 3.17% |
| Mar 31, 2025 | -19.26% |
| Dec 31, 2024 | -28.61% |
| Sep 30, 2024 | -39.87% |
| Jun 30, 2024 | -41.82% |
| Mar 31, 2024 | -104.19% |
| Dec 31, 2023 | -25.75% |
| Sep 30, 2023 | -23.06% |
| Jun 30, 2023 | -28.13% |
| Mar 31, 2023 | -32.59% |
| Dec 31, 2022 | -31.23% |
| Sep 30, 2022 | -19.91% |
| Jun 30, 2022 | -20.74% |
| Mar 31, 2022 | -30.26% |
| Dec 31, 2021 | -35.83% |
| Sep 30, 2021 | -66.27% |
| Jun 30, 2021 | -120.43% |
| Mar 31, 2021 | -215.68% |
| Dec 31, 2020 | -18.37% |
| Sep 30, 2020 | -45.20% |
| Jun 30, 2020 | -66.40% |
| Mar 31, 2020 | -17.12% |
| Dec 31, 2019 | -26.67% |
| Sep 30, 2019 | 29.98% |
| Jun 30, 2019 | -29.30% |
| Mar 31, 2019 | 16.88% |
| Dec 31, 2018 | 49.78% |
| Sep 30, 2018 | 58.73% |
| Jun 30, 2018 | 50.79% |
| Mar 31, 2018 | 45.51% |
| Dec 31, 2017 | -6.91% |
| Sep 30, 2017 | 73.12% |
| Jun 30, 2017 | -29.20% |
| Mar 31, 2017 | -17.91% |